期刊文献+

中枢性低钠血症的临床诊治分析 被引量:1

下载PDF
导出
摘要 目的探讨中枢性低钠血症两个常见病因抗利尿激素异常分泌综合征(SIADH)与脑性盐耗综合征(CSWS)的临床鉴别诊断和治疗。方法回顾性分析中枢性低钠血症16例,其中SIADH 10例,CSWS6例,通过其临床表现及实验室指标明确诊断,确定有效的治疗方法。结果2例死亡,14例低血钠基本恢复正常。结论血容量的变化是SIADH和CSWS最可靠的区分点,中心静脉压和红细胞压积是判断血容量变化较为简单可靠的临床指标。
出处 《南方医科大学学报》 CAS CSCD 北大核心 2009年第2期372-373,共2页 Journal of Southern Medical University
  • 相关文献

参考文献7

  • 1Berkenboscb-JW, Lentz CW, Jimenez DF, et al. Cerebral salt wasting syndrome following brain injury in three pediatic patients: suggestions for rapid diagnisis and therapy [J]. Pediatr Neurosurg, 2002, 36(2): 75-9.
  • 2Harrigan MR. Cerebral salt wasting syndrome [J]. Crit Care Clin, 2001, 17(1): 125-38.
  • 3Kappy MS, Ganong CA. Cerebral salt wasting in children: the role of a trial natriuretic hormone[J]. Adv Pediatr, 1996, 43: 271-308.
  • 4Oruckaptan HH, Ozisik P, Akalan N. Prolonged cerebral salt wasting syndrone associated with the intraventricular dissemination of brain tumors report of two cases and review of theliterature [J]. Pediatr Neurosurg, 2000, 33: 16-20.
  • 5雷德强,赵洪洋.中枢性低钠血症[J].中国临床神经外科杂志,2008,13(1):55-58. 被引量:18
  • 6Damaraju S, Rajshekhar V, Chandy M. Validation study of a central venous pressure-based protocol for the management of neurosurgical patients with hyponatremia and natriuresis [J]. Neurosurgery, 1997, 40:312.
  • 7Verbalis JG. Vasopression V2 receptor antagonists [J]. J Mol Endocrinol,2002, 29: 1-9.

二级参考文献3

共引文献17

同被引文献10

  • 1程诚,黄益华.中枢性低钠血症的诊断和治疗[J].实用临床医药杂志,2007,11(2):99-100. 被引量:3
  • 2Levtchenko EN, Monnens LA. Nephrogenic, syndrome of inappropri- ate antidiuresis [ J ]. Nephrol Dial Transplant, 2010,25 : 2839 - 2843.
  • 3Esposito P, Piotti G, Bianzina S, et al. The syndrome of inappropriate antidiuresis: pathophysiology, clinical management and new thera- peutic options [ J ]. Nephron Clin Pract ,2011,119 : c62 - 73.
  • 4Rabinstein AA, Bruder N. Management of Hyponatremia and Volume Contraction[ J]. Neurocrit Care ,2011,15:354 - 360.
  • 5Potts MB, Degiacomo AF, Deragopian L, et al. Use of intravenous conivaptan in neurosurgical patients with hyponatremia from syn- drome of inappropriate antidiuretic hormone secretion [ J ]. Neurosur- gery,2011,69 :268 -273.
  • 6Velez JC, Dopson S J, Sanders DS, et al. Intravenous conivaptan for the treatment of hyponatremia caused by the syndrome of inappropri- ate secretion of antidiuretic hormone in hospitalized patients : a single center experience [ J ]. Nephrol Dial Transplant, 2010,25 : 1524 - 1531.
  • 7Zmily HD, Daifallah S, Ghali JK. Tolvaptan, hyponatremia, and heart failure[ J]. Int J Nephml Renovasc Dis,2011,4:57 -71.
  • 8Nemerovski C, Hutchinson DJ. Treatment of hypervolemic or euv- olemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review[ J]. Clin Ther,2010,32 : 1015 - 1032.
  • 9Wong F, Blei AT, Blendis LM, et al. A vasopressin receptor antago- nist(VPA-985) improves serum sodium concentration in patients with hyponatremia: a muhicenter, randomized, placebo-cc~ntrolled trial[ J]. Hepatology ,2003,37 : 182 - 191.
  • 10Berl T, Quittnat-Pelletier F, Verbalis JG, et al. SALTWATER In- vestigators: Oral tolvaptan is safe and effective in chronic hy- ponatremia[ J]. J Am Soc Nephrol,2010,21:705 -712.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部